Basilea Pharmaceutica Ltd
Ronald Scott, Swiss citizen, has served as Chief Executive Officer since January 2013. He was Basilea's Chief Operating Officer from January 2012 through December 2012, and served as Basilea's Chief Financial Officer from the Company’s founding in 2000 through January 2012 as well as ad interim Chief Financial Officer from February 2013 until November 2013. From 2004 to October 2011, Mr. Scott served on the Board of Directors. Prior to joining Basilea, Mr. Scott worked at Roche Holding AG (Roche) in management positions in Pharmaceutical Finance, Licensing, and the Roche Corporate Finance Mergers and Acquisitions group. Prior to joining Roche, Mr. Scott worked for Prudential Investment Corporation in the United States as Director in Prudential’s Finance and International Business Development Units, managing divestitures and joint venture transactions. In May 2017, Mr. Scott was elected as a member of the Supervisory Board of Medigene AG (Germany). Mr. Scott has a bachelor’s degree from Utah State University (USA) and a master’s degree from Harvard University (USA).